Rising Cost of Cancer Pharmaceuticals: Cost Issues and Interventions to Control Costs
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rising Cost of Cancer Pharmaceuticals: Cost Issues and Interventions to Control Costs
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume 37, Issue 1, Pages 85-93
Publisher
Wiley
Online
2016-11-15
DOI
10.1002/phar.1867
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Equity in Cancer Care: Pathways, Protocols, and Guidelines
- (2017) Jessica K. DeMartino et al. Journal of the National Comprehensive Cancer Network
- The High Cost of Prescription Drugs in the United States
- (2016) Aaron S. Kesselheim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- Overspending driven by oversized single dose vials of cancer drugs
- (2016) Peter B Bach et al. BMJ-British Medical Journal
- Overspending driven by oversized single dose vials of cancer drugs
- (2016) Peter B Bach et al. BMJ-British Medical Journal
- ReCAP: Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care
- (2016) Ivy Altomare et al. Journal of Oncology Practice
- American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology
- (2016) Robin T. Zon et al. Journal of Oncology Practice
- American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
- (2015) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- High Cancer Drug Prices in the United States: Reasons and Proposed Solutions
- (2014) Hagop Kantarjian et al. Journal of Oncology Practice
- Market spiral pricing of cancer drugs
- (2013) Donald W . Light et al. CANCER
- Cancer Drugs in the United States: Justum Pretium—The Just Price
- (2013) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- The High Cost of Cancer Drugs and What We Can Do About It
- (2012) Mustaqeem Siddiqui et al. MAYO CLINIC PROCEEDINGS
- The economic pressures for biosimilar drug use in cancer medicine
- (2012) Paul Cornes Targeted Oncology
- Monoclonal antibodies: magic bullets with a hefty price tag
- (2012) A. F. Shaughnessy BMJ-British Medical Journal
- Projections of the Cost of Cancer Care in the United States: 2010-2020
- (2011) A. B. Mariotto et al. JNCI-Journal of the National Cancer Institute
- Strategic Use of Clinical Pathways
- (2011) Dean H. Gesme et al. Journal of Oncology Practice
- Analysis of Manufacturing Costs in Pharmaceutical Companies
- (2008) Prabir Basu et al. Journal of Pharmaceutical Innovation
- Improving Pharmaceutical Product Development and Manufacturing: Impact on Cost of Drug Development and Cost of Goods Sold of Pharmaceuticals
- (2008) Pradeep Suresh et al. Journal of Pharmaceutical Innovation
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now